Phyllis Trust
Family Medicine · Canfield, OHNPI 1194085811
Payments from drug & device makers
Across 174 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$642
- Dexcom, Inc.$528
- Novo Nordisk$414
- Medtronic$187
- Insulet Corporation$118
- Xeris Pharmaceuticals, Inc.$106
- plus $786 from 18 others
What the payments were for
- Food & beverage$2,781100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 52 | $642 |
| Dexcom, Inc. | 17 | $528 |
| Novo Nordisk | 44 | $414 |
| Medtronic(2 entities) | 7 | $187 |
| Insulet Corporation | 7 | $118 |
| Xeris Pharmaceuticals, Inc. | 5 | $106 |
| Tandem Diabetes Care, Inc. | 8 | $100 |
| AbbVie | 5 | $79 |
| Lilly USA, LLC | 4 | $78 |
| Ascensia Diabetes Care US Inc. | 2 | $67 |
| Abbott | 3 | $65 |
| Corcept Therapeutics | 3 | $61 |
| Novartis | 3 | $50 |
| Amgen | 2 | $43 |
| Antares Pharma, Inc. | 2 | $35 |
| IBSA Pharma Inc. | 2 | $33 |
| Intrabio Inc | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $25 |
| BETA Bionics, Inc. | 1 | $24 |
| Pfizer | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Ascendis Pharma Endocrinology Inc | 1 | $21 |
| AstraZeneca | 1 | $18 |
| Recordati_rare_diseases_inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,781 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 181 | $307,461 |
| JardianceEmpagliflozin | 197 | $241,313 |
| TrulicityDulaglutide | 114 | $213,675 |
| MounjaroTirzepatide | 76 | $121,860 |
| FarxigaDapagliflozin Propanediol | 47 | $54,279 |
| Humalog Kwikpen U-100Insulin Lispro | 90 | $44,192 |
| KerendiaFinerenone | 31 | $42,392 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 38 | $40,475 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 200 | $37,950 |
| Repatha SureclickEvolocumab | 25 | $37,536 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $28,929 |
| Tresiba Flextouch U-100Insulin Degludec | 34 | $28,080 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 60 | $27,586 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 14 | $23,677 |
| VascepaIcosapent Ethyl | 32 | $22,222 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $78 | $335,535190 claims |
| Novo NordiskOzempic, Rybelsus | $414 | $324,811195 claims |
| AstraZenecaFarxiga | $18 | $54,27947 claims |
| BayerKerendia | $642 | $42,39231 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $22 | $29,09428 claims |
| AbbVieSynthroid | $79 | $2,86541 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Canfield
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.